Download Cerebral Amyloid Angiopathy Criteria The Next Generation Pdf May 2026

The Boston criteria version 2.0 for cerebral amyloid angiopathy

: Enlarged fluid spaces in the deep white matter. The Boston criteria version 2

The v2.0 criteria significantly increase diagnostic sensitivity—capturing more true cases without losing specificity—by broadening the biological markers recognized by MRI. The Boston criteria version 2

: Specific patterns of white matter damage. Clinical Significance The Boston criteria version 2

The "next generation" of cerebral amyloid angiopathy (CAA) diagnosis is defined by the , released in late 2022 to replace the 2010 modified criteria. This update shifts the diagnostic paradigm from purely hemorrhagic markers to a more holistic "small vessel disease" profile, integrating white matter signatures. Key Evolutions in the Next Generation Criteria